GNTA — Genenta Science S.p.A.

Nasdaq · Health Care · Biotechnology · CIK 1838716 ·
Last close
$1.15
Market Cap
$55.45M
52W High
$2.58
52W Low
$0.55
ADV30
62,866
Next earnings
Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is developing Temferon for use in the treatment of other solid tumor indications. In addition, the company develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 31,889,310 5,527,672 10,048,670
Dec 2024 14,823,993 4,581,749 2,328,287

Balance + Analyst (yfinance extras)

Retained Earnings
$-62,585,347
Inventory
Receivables
$1,285,630
ST Investments
$22,621,518
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 0 -6,603,740 -6,529,827 31,889,310 10,048,670 -6,867,959
Dec 2024 0 -9,764,310 -8,912,495 14,823,993 2,328,287 -6,240,174
Dec 2023 0 -11,732,942 -11,645,455 22,347,145 1,914,888 -11,205,023
Dec 2022 0 -11,043,992 -8,477,763 33,437,860 2,299,694 -7,418,236

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.65

Peers — same industry

TickerNameMarket CapLastDaily %
TIL Instil Bio, Inc. $52.97M $7.81
ATYR aTYR PHARMA INC $51.99M $0.53
INKT MiNK Therapeutics, Inc. $60.32M $11.82
BKHA Black Hawk Acquisition Corp $49.39M $11.89
TCRX TScan Therapeutics, Inc. $48.82M $0.80

News headlines (Yahoo Finance, 1h cache)

Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
2026-07-23 07:09 · Yahoo
Genenta signs Definitive Agreements with Sophia High Tech
2026-04-23 11:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Friday
2026-07-17 14:57 · Yahoo
Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
2026-07-22 08:00 · Yahoo
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
2026-03-27 09:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Higher Tuesday
2026-03-17 15:18 · Yahoo
Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business
2026-02-28 00:53 · Yahoo
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
2026-01-27 08:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Gain Friday
2026-01-02 16:09 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.